We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$26.7B
AUM Growth
+$3.85B
Cap. Flow
-$4.59B
Cap. Flow %
-17.17%
Top 10 Hldgs %
20.41%
Holding
1,231
New
232
Increased
271
Reduced
149
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRONU
751
DELISTED
Corner Growth Acquisition Corp. 2 Units
TRONU
$1.32M ﹤0.01%
125,000
AGNT
752
AGNT Inc
AGNT
$661M
$1.31M ﹤0.01%
38,947
-64,311
-62% -$2.65M
SONY icon
753
Sony
SONY
$133B
$1.31M ﹤0.01%
+51,790
New +$1.23M
AEHAU
754
DELISTED
Aesther Healthcare Acquisition Corp Units
AEHAU
$1.3M ﹤0.01%
125,000
RAMMU
755
DELISTED
Aries I Acquisition Corporation Unit
RAMMU
$1.3M ﹤0.01%
125,000
SBOW
756
DELISTED
SilverBow Resources, Inc.
SBOW
$1.27M ﹤0.01%
+58,464
New +$1.53M
ENCPU
757
DELISTED
Energem Corp Unit
ENCPU
$1.27M ﹤0.01%
+125,000
New +$1.27M
MPWR icon
758
Monolithic Power Systems
MPWR
$63B
$1.27M ﹤0.01%
2,569
-1,024
-28% -$529K
BCE icon
759
BCE
BCE
$20.3B
$1.21M ﹤0.01%
+23,184
New +$1.19M
XPOF icon
760
Xponential Fitness
XPOF
$282M
$1.2M ﹤0.01%
+58,641
New +$1.09M
CCL icon
761
Carnival Corporation Ltd
CCL
$38.7B
$1.19M ﹤0.01%
59,260
BSKYU
762
DELISTED
Big Sky Growth Partners, Inc. Unit
BSKYU
$1.17M ﹤0.01%
119,900
TNDM icon
763
Tandem Diabetes Care
TNDM
$1.22B
$1.15M ﹤0.01%
+7,661
New +$1.03M
FERG icon
764
Ferguson
FERG
$45B
$1.14M ﹤0.01%
+6,343
New +$994K
BRZE icon
765
Braze
BRZE
$2.83B
$1.09M ﹤0.01%
+14,086
New +$1.02M
APEN
766
DELISTED
Apollo Endosurgery, Inc.
APEN
$1.08M ﹤0.01%
+128,564
New +$1.12M
OTECU
767
DELISTED
OceanTech Acquisitions I Corp. Units
OTECU
$1.04M ﹤0.01%
100,000
DVN icon
768
Devon Energy
DVN
$49.2B
$1.03M ﹤0.01%
23,500
SAP icon
769
SAP
SAP
$209B
$1.02M ﹤0.01%
+7,248
New +$1.01M
SMAPU
770
DELISTED
SportsMap Tech Acquisition Corp. Units
SMAPU
$1.02M ﹤0.01%
+100,000
New +$1.02M
HTAQ.U
771
DELISTED
Hunt Companies Acquisition Corp. I Units, each consisting of one Class A ordinary share and one-half one redeemable warrant
HTAQ.U
$1.01M ﹤0.01%
+100,000
New +$1.01M
PHYT.U
772
DELISTED
Pyrophyte Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
PHYT.U
$1.01M ﹤0.01%
+100,000
New +$1.01M
BKLN icon
773
Invesco Senior Loan ETF
BKLN
$6.97B
$1.01M ﹤0.01%
45,865
GVCIU
774
DELISTED
Green Visor Financial Technology Acquisition Corp. I Units
GVCIU
$1.01M ﹤0.01%
+100,000
New +$1.01M
APCA.U
775
DELISTED
AP Acquisition Corp Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
APCA.U
$1.01M ﹤0.01%
+100,000
New +$1.01M

Similar funds

Calamos Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.

  • Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
  • Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
  • Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
  • Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
  • Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
  • Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.